Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 56 min ago
Peer-reviewedCC BY-NC-ND 4.0JACC: CardioOncology

Long-Term Cardiovascular Care After Cytokine Release Syndrome

  • Belén Terol1
  • Ana Martín-García2
  • Dimitrios Farmakis3
  • Rocío Eiros2
  • Irene Sánchez Vadillo4
  • Raúl Córdoba5
  • Teresa Lopez-Fernandez6
6 affiliations
  1. 1Cardio-Oncology Unit, Cardiology Department, Hospital Quironsalud Madrid, Madrid, Spain
  2. 2Cardiology Department, University Hospital of Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), CIBERCV, Instituto de Salud Carlos III (ISCIII), Universidad de Salamanca, Salamanca, Spain
  3. 3Department of Cardiology, Athens University Hospital Attikon, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
  4. 4Cardio-Oncology Unit, Hematology Department, La Paz University Hospital, IdiPAZ Research Institute, Madrid, Spain
  5. 5Department of Hematology, MD Anderson Cancer Center Madrid Hospiten, Madrid, Spain
  6. 6Cardio-Oncology Unit, Cardiology Department, La Paz University Hospital, IdiPAZ Research Institute, Madrid, Spain
Read full textPDFDOICite

Related

  1. Atypical cytokine release syndrome induced by carboplatin: The first described case report
    Maria Cruz Torres Górriz, Julian Borrás Cuartero, Anna Bosh Requena +2
    International Journal of Immunopathology and PharmacologyPeer-reviewedCC BY-NC 4.0Full text1 citedPharmacology & toxicologyPMC
  2. Immunobiology and Immune-Related Toxicities of Cancer Immunotherapy: Organ-Specific Immune-Related Adverse Events, Cytokine Release Syndrome, and Immune Effector Cell–Associated Neurotoxicity Syndrome
    Stanley Kim, Fred Schiffman, Matthew Hadfield +6
    Journal of Brown hospital medicinePeer-reviewedCC BY-NCFull textOncologyEurope PMCPMC
  3. INTEGRATED IMMUNOPHENOTYPING REVEALS DISTINCT MULTICOMPARTMENT IMMUNE SIGNATURES ASSOCIATED WITH CYTOKINE RELEASE SYNDROME FOLLOWING ANTI-CD19 CAR-T CELL THERAPY
    Mariana Soares GOMES, Arianne Fagotti GUSMãO, Larissa Campos SOUZA +15
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textOncologyDOAJ
  4. Lipoprotein(a), smoking, and diabetes are additive but not interactive risk factors for major adverse cardiovascular events after acute coronary syndrome
    Gregory G. Schwartz, Michael Szarek, Vera A. Bittner +11
    American journal of preventive cardiologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Nintedanib-induced Glomerular Microangiopathy after Long-term Nintedanib Administration Presenting with Nephrotic Syndrome
    Mizuki Watada, Yurina Yataka, Motoki Hoshino +4
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE

Cite

BibTeXRIS
BibTeX
@article{terol2026longterm,
  title = {{Long-Term Cardiovascular Care After Cytokine Release Syndrome}},
  author = {Belén Terol and Ana Martín-García and Dimitrios Farmakis and Rocío Eiros and Irene Sánchez Vadillo and Raúl Córdoba and Teresa Lopez-Fernandez},
  journal = {JACC: CardioOncology},
  year = {2026},
  month = oct,
  doi = {10.1016/j.jaccao.2026.08.006},
  url = {https://doi.org/10.1016/j.jaccao.2026.08.006},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Long-Term Cardiovascular Care After Cytokine Release Syndrome
AU  - Belén Terol
AU  - Ana Martín-García
AU  - Dimitrios Farmakis
AU  - Rocío Eiros
AU  - Irene Sánchez Vadillo
AU  - Raúl Córdoba
AU  - Teresa Lopez-Fernandez
PY  - 2026
DA  - 2026/10/01
JO  - JACC: CardioOncology
DO  - 10.1016/j.jaccao.2026.08.006
UR  - https://doi.org/10.1016/j.jaccao.2026.08.006
SN  - 2666-0873
ER  -